Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aram Gyulkhandanyan

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Oncotarget|September 8, 2018
Online structure-based screening of purchasable approved drugs and natural compounds: retrospective examples of drug repositioning on cancer targetsNathalie Lagarde, Julien Rey, Aram Gyulkhandanyan, et al.
Journal of Biomolecular Structure & Dynamics|August 9, 2012
Assessment of new cationic porphyrin binding to plasma proteins by planar microarray and spectroscopic methodsAram Gyulkhandanyan, Lusine Gyulkhandanyan, Robert Ghazaryan, et al.
Molecular Genetics & Genomic Medicine|February 26, 2020
Analysis of protein missense alterations by combining sequence- and structure-based methodsAram Gyulkhandanyan, Alireza R Rezaie, Lubka Roumenina, et al.
Cancers|August 4, 2019
Targeting Degradation of EGFR through the Allosteric Site Leads to Cancer Cell Detachment-Promoted DeathMelkon Iradyan, Nina Iradyan, Philippe Hulin, et al.
Scientific Reports|February 6, 2014
Screening and discovery of nitro-benzoxadiazole compounds activating epidermal growth factor receptor (EGFR) in cancer cellsVehary Sakanyan, Marie Angelini, Mickael Le Béchec, et al.
Journal of the American Society of Nephrology : JASN|February 9, 2020
Anti-Factor B Antibodies and Acute Postinfectious GN in ChildrenSophie Chauvet, Romain Berthaud, Magali Devriese, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Oncotarget|September 8, 2018
Online structure-based screening of purchasable approved drugs and natural compounds: retrospective examples of drug repositioning on cancer targetsNathalie Lagarde, Julien Rey, Aram Gyulkhandanyan, et al.
Journal of Biomolecular Structure & Dynamics|August 9, 2012
Assessment of new cationic porphyrin binding to plasma proteins by planar microarray and spectroscopic methodsAram Gyulkhandanyan, Lusine Gyulkhandanyan, Robert Ghazaryan, et al.
Molecular Genetics & Genomic Medicine|February 26, 2020
Analysis of protein missense alterations by combining sequence- and structure-based methodsAram Gyulkhandanyan, Alireza R Rezaie, Lubka Roumenina, et al.
Cancers|August 4, 2019
Targeting Degradation of EGFR through the Allosteric Site Leads to Cancer Cell Detachment-Promoted DeathMelkon Iradyan, Nina Iradyan, Philippe Hulin, et al.
Scientific Reports|February 6, 2014
Screening and discovery of nitro-benzoxadiazole compounds activating epidermal growth factor receptor (EGFR) in cancer cellsVehary Sakanyan, Marie Angelini, Mickael Le Béchec, et al.
Journal of the American Society of Nephrology : JASN|February 9, 2020
Anti-Factor B Antibodies and Acute Postinfectious GN in ChildrenSophie Chauvet, Romain Berthaud, Magali Devriese, et al.
Pageof 1